These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37930197)

  • 1. The Need for Examining the Role of Psychostimulants in Treatment of Methamphetamine Use/Dependence.
    Balon R
    J Clin Psychopharmacol; 2023 Nov-Dec 01; 43(6):483-484. PubMed ID: 37930197
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of psychostimulants for amphetamine and methamphetamine use disorders: a systematic review and meta-analysis.
    Bhatt M; Zielinski L; Baker-Beal L; Bhatnagar N; Mouravska N; Laplante P; Worster A; Thabane L; Samaan Z
    Syst Rev; 2016 Nov; 5(1):189. PubMed ID: 27842569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulant substitution in methamphetamine dependence.
    Dobry Y; Sher L
    Aust N Z J Psychiatry; 2012 Dec; 46(12):1201-2. PubMed ID: 22689332
    [No Abstract]   [Full Text] [Related]  

  • 4. Prescription psychostimulants as a harm reduction and treatment intervention for methamphetamine use disorder and the implications for nursing clinical practice: A scoping review of the literature.
    Leidl D; Takhar P; Li H
    Int J Ment Health Nurs; 2023 Oct; 32(5):1225-1242. PubMed ID: 36978242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ling et al.'s 'Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder'.
    Levin FR; Mariani JJ; Bisaga A; Nunes EV
    Addiction; 2015 May; 110(5):875-6. PubMed ID: 25808040
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacological Treatment of Methamphetamine/Amphetamine Dependence: A Systematic Review.
    Siefried KJ; Acheson LS; Lintzeris N; Ezard N
    CNS Drugs; 2020 Apr; 34(4):337-365. PubMed ID: 32185696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapeutic agents in the treatment of methamphetamine dependence.
    Morley KC; Cornish JL; Faingold A; Wood K; Haber PS
    Expert Opin Investig Drugs; 2017 May; 26(5):563-578. PubMed ID: 28351169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Substitution therapy tested against amphetamine dependence].
    Bloniecki Kallio V; Guterstam J; Franck J
    Lakartidningen; 2016 Jan; 113():. PubMed ID: 26756343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of psychostimulant drugs for amphetamine abuse or dependence.
    Pérez-Mañá C; Castells X; Torrens M; Capellà D; Farre M
    Cochrane Database Syst Rev; 2013 Sep; (9):CD009695. PubMed ID: 23996457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical management of psychostimulant withdrawal: review of the evidence.
    Li MJ; Shoptaw SJ
    Addiction; 2023 Apr; 118(4):750-762. PubMed ID: 36401591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modafinil for bipolar depression with comorbid methamphetamine abuse.
    Camacho A; Ng B; Frye MA
    Am J Addict; 2010; 19(2):190-1. PubMed ID: 20163392
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of stimulants to treat cocaine and methamphetamine abuse.
    Moeller FG; Schmitz JM; Herin D; Kjome KL
    Curr Psychiatry Rep; 2008 Oct; 10(5):385-91. PubMed ID: 18803911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatments for methamphetamine abuse: a literature review for the clinician.
    Brackins T; Brahm NC; Kissack JC
    J Pharm Pract; 2011 Dec; 24(6):541-50. PubMed ID: 22095579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials.
    Kishi T; Matsuda Y; Iwata N; Correll CU
    J Clin Psychiatry; 2013 Dec; 74(12):e1169-80. PubMed ID: 24434105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topiramate for the management of methamphetamine dependence: a pilot randomized, double-blind, placebo-controlled trial.
    Rezaei F; Ghaderi E; Mardani R; Hamidi S; Hassanzadeh K
    Fundam Clin Pharmacol; 2016 Jun; 30(3):282-9. PubMed ID: 26751259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Could sigma receptor ligands be a treatment for methamphetamine addiction?
    Rodvelt KR; Miller DK
    Curr Drug Abuse Rev; 2010 Sep; 3(3):156-62. PubMed ID: 21054260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study protocol: a dose-escalating, phase-2 study of oral lisdexamfetamine in adults with methamphetamine dependence.
    Ezard N; Dunlop A; Clifford B; Bruno R; Carr A; Bissaker A; Lintzeris N
    BMC Psychiatry; 2016 Dec; 16(1):428. PubMed ID: 27905916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological treatments for methamphetamine addiction: current status and future directions.
    Ballester J; Valentine G; Sofuoglu M
    Expert Rev Clin Pharmacol; 2017 Mar; 10(3):305-314. PubMed ID: 27927042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot randomised controlled trial of modafinil during acute methamphetamine withdrawal: feasibility, tolerability and clinical outcomes.
    Lee N; Pennay A; Hester R; McKetin R; Nielsen S; Ferris J
    Drug Alcohol Rev; 2013 Jan; 32(1):88-95. PubMed ID: 22630616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended-release methylphenidate for treatment of amphetamine/methamphetamine dependence: a randomized, double-blind, placebo-controlled trial.
    Miles SW; Sheridan J; Russell B; Kydd R; Wheeler A; Walters C; Gamble G; Hardley P; Jensen M; Kuoppasalmi K; Tuomola P; Föhr J; Kuikanmäki O; Vorma H; Salokangas R; Mikkonen A; Kallio M; Kauhanen J; Kiviniemi V; Tiihonen J
    Addiction; 2013 Jul; 108(7):1279-86. PubMed ID: 23297867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.